Citadel Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$936K Buy
207,642
+53,687
+35% +$242K ﹤0.01% 3380
2025
Q1
$682K Sell
153,955
-67,959
-31% -$301K ﹤0.01% 3673
2024
Q4
$1.74M Sell
221,914
-52,633
-19% -$412K ﹤0.01% 2744
2024
Q3
$3.61M Buy
274,547
+12,803
+5% +$168K ﹤0.01% 2020
2024
Q2
$3.16M Buy
261,744
+143,443
+121% +$1.73M ﹤0.01% 2032
2024
Q1
$1.92M Sell
118,301
-19,199
-14% -$312K ﹤0.01% 2528
2023
Q4
$938K Sell
137,500
-276,807
-67% -$1.89M ﹤0.01% 3095
2023
Q3
$2.26M Buy
414,307
+382,794
+1,215% +$2.09M ﹤0.01% 2292
2023
Q2
$214K Sell
31,513
-274,197
-90% -$1.86M ﹤0.01% 4395
2023
Q1
$1.53M Sell
305,710
-654,711
-68% -$3.28M ﹤0.01% 2770
2022
Q4
$4.69M Buy
960,421
+869,961
+962% +$4.25M ﹤0.01% 1842
2022
Q3
$1.3M Buy
+90,460
New +$1.3M ﹤0.01% 3151
2022
Q2
Sell
-26,927
Closed -$320K 7022
2022
Q1
$320K Sell
26,927
-98,771
-79% -$1.17M ﹤0.01% 4884
2021
Q4
$2.04M Buy
125,698
+21,183
+20% +$343K ﹤0.01% 3034
2021
Q3
$2.98M Sell
104,515
-70,670
-40% -$2.02M ﹤0.01% 2560
2021
Q2
$5.92M Buy
175,185
+83,790
+92% +$2.83M ﹤0.01% 1964
2021
Q1
$2.76M Sell
91,395
-24,074
-21% -$728K ﹤0.01% 2813
2020
Q4
$5.72M Buy
115,469
+106,301
+1,159% +$5.26M ﹤0.01% 1667
2020
Q3
$352K Sell
9,168
-3,832
-29% -$147K ﹤0.01% 3735
2020
Q2
$561K Sell
13,000
-24,913
-66% -$1.08M ﹤0.01% 3362
2020
Q1
$990K Sell
37,913
-32,415
-46% -$846K ﹤0.01% 2876
2019
Q4
$2.2M Buy
+70,328
New +$2.2M ﹤0.01% 2268